IROQ - Comprehensive Filing Intelligence
Q2 2026•10-Q•Filed Feb 12, 2026
5.0/10
Filing Health:CAUTION
Notable concerns that warrant closer review
Executive Summary
Net interest income significantly improved due to a wider interest rate spread and decreased interest expenses, boosting overall profitability.. Noninterest income declined, primarily due to lower gains on securities sales and a one-time prior period insurance settlement, despite growth in loan sales and service fees.. The company has significant off-balance sheet credit exposures related to commitments to make loans and commercial letters of credit, with an Allowance for Credit Losses (ACL) on these exposures of $39,000 as of December 31, 2025.. Net income increased to $2.7M from $1.9M in the prior period.
Top Concerns
- !Noninterest income declined, primarily due to lower gains on securities sales and a one-time prior period insurance settlement, despite growth in loan sales and service fees.
- !The company has significant off-balance sheet credit exposures related to commitments to make loans and commercial letters of credit, with an Allowance for Credit Losses (ACL) on these exposures of $39,000 as of December 31, 2025.
- !While the company states it is subject to legal actions, management believes their resolution will not materially impact financial condition or results of operations.
- !Regulatory Capital Requirements (medium)
- !Capital Structure and Interest Income Management (low)
Top Positives
- +Net interest income significantly improved due to a wider interest rate spread and decreased interest expenses, boosting overall profitability.
- +Noninterest income declined, primarily due to lower gains on securities sales and a one-time prior period insurance settlement, despite growth in loan sales and service fees.
- +Operating expenses increased, largely driven by professional services related to a pending merger, which may impact future margins if not controlled.